CHI Advisors’s Entrada Therapeutics TRDA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-56,374	Closed	-$817K	–	27
2023 Q1	$817K	Buy	+56,374	New	+$817K	0.22%	22
2022 Q3	–	Sell	-163,496	Closed	-$1.99M	–	26
2022 Q2	$1.99M	Buy	+163,496	New	+$1.99M	0.76%	22